• 科學家破解癌症相關酵素的密碼,為新療法開啟大門

    根據國際癌症研究機構(IARC)的數據,癌症仍是全球主要死亡原因之一。2022 年,全球估計有 2000 萬例新發病例與 970 萬例死亡。近期,兩項刊登於《美國化學學會期刊》的新研究,深入探討了與癌症息息相關的人類 β-1,3-半乳糖基轉移酵素 5(β3GalT5)。 Read More
  • 2025大學生暑期培育計畫-開始報名!

    科研是一場無盡的探索與發現之旅!誠摯邀請充滿熱忱與好奇心的你,一起挑戰自我、拓展視野,深入科研世界,點燃你的學術熱情!這個暑假不留白,就從基因體暑大生計畫開始! Read More
  • 馬徹研究員榮獲國家科學及技術委員會113年度傑出研究獎

    馬徹研究員專長於結構生物學,研究聚焦膜蛋白與醣蛋白在傳染病及癌症中的關鍵角色。特別是近年來對於新冠肺炎病毒的治療與預防、設計新型抗生素藥物等有三項成果... Read More
  • GRC-Harvard Griffin IDDH-HGG青年健康科學研習營

    2024年暑假,基因體中心與哈佛大學公共衛生學院梁黎明教授團隊首度攜手,成功舉辦健康科學研習營,獲得熱烈迴響!今年,我們再度邀請梁教授及其團隊,讓更多學生有機會與哈佛學者零距離交流,透過沉浸式學習,提前探索健康科學的研究世界! Read More
  • 基因體研究中心二十週年活動

    基因體研究中心20歲了!為慶祝這具有里程碑意義的時刻,本中心於113年12月11日(三)舉辦20週年慶祝活動。感謝歷屆中心成員、合作夥伴及各界貴賓的參與,共同見證中心的成長與茁壯。 Read More
  • 陳韻如老師研究團隊榮獲2024國家新創精進獎

    神經退化性疾病藥物大多是減緩症狀而無針對致病標的。本團隊的新創研發抗體藥物會專一辨認錯誤折疊的TDP-43寡聚體(oligomer),不會辨認正常的TDP-43。研究證實誤折疊的TDP-43寡聚體具有神經毒性,並存在於... Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

Language

獲獎與人事消息

  • 恭喜阮麗蓉老師實驗室周建德博士與博士班學生林怡斈獲得第30屆細胞及分子生物新知研討會暨30屆慶祝活動之騰達行優秀壁報論文獎的第三名與佳作
    Read More
  • 恭喜胡春美老師實驗室吳丹霓小姐獲得114年度國際研究生學程博士生「研究進步獎學金」
    Read More
  • 113年度研究績優人員表揚
    Read More
  • 恭喜陳韻如老師實驗室蔡天穎博士獲得2024年永信李天德醫藥基金會壁報論文特優獎
    Read More

研究分享系列

  • All
  • 研究消息
  • 科普演講
load more hold SHIFT key to load all load all

Chen, Ding-Shinn 陳定信

DSChen6x7客座講座


Email: Email住址會使用灌水程式保護機制。你需要啟動Javascript才能觀看它
 



EDUCATION AND POSITIONS HELD:

  • MD, National Taiwan University School of Medicine, 1968
  • Resident, Department of Internal Medicine, National Taiwan University Hospital, 1969-73
  • Associate Professor, National Taiwan University College of Medicine, Taipei, Taiwan, 1978-83
  • Visiting Scientist, National Institutes of Health, Bethesda, USA, 1979-80
  • Professor of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan, 1983-2013
  • Founding Director, Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan, 1987-2001
  • Dean, National Taiwan University College of Medicine, Taipei, Taiwan, 2001-2007

HONORS:

  • National Outstanding Science and Technology Award of the Republic of China, Executive Yuan, Taiwan, 1984
  • Abbott Laboratories Research Award, Abbott Laboratories, USA, 1986
  • Outstanding Research Award in Biology and Medicine, National Science Council, Taiwan, 1987-1993
  • Outstanding Academic Award (Medicine), Ministry of Education, Taiwan, 1989
  • Academician, Academia Sinica, Taiwan, 1992
  • Grand Award, Society of Chinese Bioscientists in America (SCBA), USA, 1993
  • Hou Jin-Duei Outstanding Contribution Award in Basic Science, Taiwan, 1994
  • Outstanding Scholar Award, Foundation for the Advancement of Outstanding Scholarship, Taiwan, 1995-1999
  • National Chair-Professor of Medicine, Ministry of Education, Taiwan, 1997-2003
  • Lifetime National Chair-Professor of Medicine, Ministry of Education, Taiwan, 2004
  • Fellow, The Third World Academy of Sciences (TWAS), Italy, 2001
  • Doctor of Philosophy (honoris causa), Kaohsiung Medical University, Taiwan, 2002
  • Foreign Associate, National Academy of Sciences, USA, 2005
  • Caring Physicians of the World, World Medical Association, France, 2005
  • Outstanding Achievement Award, Foundation for the Advancement of Outstanding Scholarship, Taiwan, 2005
  • Trieste Science Prize, TWAS, Italy, 2006
  • Presidential Science Prize of Taiwan, Taiwan, 2007
  • EASL International Recognition Award, Denmark, 2009
  • Okuda Lectureship Award, JGH Foundation, Australia, 2009
  • Nikkei Asia Prize, Japan, 2010
  • Distinguished Clinician Educator/Mentor Award, AASLD, San Francisco, 2011
  • President’s Award, Chung-Hwa Rotary Educational Foundation, Taichung, 2014
  • Doctor of Philosophy (honoris causa), China Medical University, Taichung, 2014
  • TASL Mentor Award, Taiwan Association for the Study of the Liver, Taiwan, 2015
  • First Rank Health & Welfare Medal, Ministry of Health and Welfare, Taiwan, 2015

RESEARCH INTERESTS:

Dr. Chen’s research interest continues to be in the basic and clinical aspects of viral hepatitis and liver disease, ranging from prevention to management.

In the last 40 years, although he and his colleagues have solved many problems of liver disease in Taiwan, there are still a lot of unresolved issues. They will continue to address these issues in chronic hepatitis B infection and its implications (Science 1993; 262:369-70). In addition, chronic hepatitis C will be another important topic.

Dr. Chen’s current major efforts are to explore these issues by using a mouse-model of chronic hepatitis B virus (HBV) infection his team has established before (PNAS 2006; 103:17862-7). With this animal model, they hope to explore the mechanism of persistent hepatitis B infection, e. g., why is the infection associated with chronicity especially in young age, the genetic and immunologic background of persistent infection, etc. Preliminary results showed that HBV persistence was closely related to the establishment of gut microbiota, and TLR4 played a critical role (PNAS 2015; 112:2175-80). They will further dissect the mechanism of HBV persistence focusing on the roles of Kupffer cells in the innate immunity against HBV as well as the natural killer cells and other immune cells in breaking the tolerance to HBV persistence. These results may disclose novel immunologic mechanisms of HBV persistence and then provide new targets for futher effective therapy. The results will hopefully be translated to clinical settings in humans.

DSChenFig3

As a clinician, Dr. Chen still keeps translational and clinical research on chronic hepatitis B and C as well as liver cirrhosis and hepatocellular carcinoma. His academic achievements can be seen from his publications as shown in PubMed.